Literature DB >> 9685410

Tuberous sclerosis gene 2 product modulates transcription mediated by steroid hormone receptor family members.

K W Henry1, X Yuan, N J Koszewski, H Onda, D J Kwiatkowski, D J Noonan.   

Abstract

Tuberous sclerosis (TSC) is a genetic disorder that results in the development of hamartomatous lesions in a variety of organ systems. Both the prevalence of the disease and the often devastating consequences of these tumors pose a serious health and medical care problem. The disease has been mapped to two distinct genetic loci in humans, and although the genes (TSC1 and TSC2) for both loci have recently been cloned, their function remains an enigma. Data presented here demonstrates that TSC2 protein can bind and selectively modulate transcription mediated by members of the steroid receptor superfamily of genes. These data place TSC2 into a growing list of nuclear receptor coregulators and strengthen the expanding body of evidence that these coregulators may play critical roles in cellular differentiation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9685410     DOI: 10.1074/jbc.273.32.20535

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis.

Authors:  T Carsillo; A Astrinidis; E P Henske
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

2.  Tuberin--a new molecular target in Alzheimer's disease?

Authors:  Rosa Ferrando-Miguel; Margit Rosner; Angelika Freilinger; Gert Lubec; Markus Hengstschläger
Journal:  Neurochem Res       Date:  2005-11       Impact factor: 3.996

3.  Lymphangioleiomyomatosis.

Authors:  Angelo M Taveira-DaSilva; Wendy K Steagall; Joel Moss
Journal:  Atlas Genet Cytogenet Oncol Haematol       Date:  2009

4.  Tsc2(+/-) mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background.

Authors:  H Onda; A Lueck; P W Marks; H B Warren; D J Kwiatkowski
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

Review 5.  Everolimus tablets for patients with subependymal giant cell astrocytoma.

Authors:  Scott G Turner; Katherine B Peters; James J Vredenburgh; Annick Desjardins; Henry S Friedman; David A Reardon
Journal:  Expert Opin Pharmacother       Date:  2011-08-01       Impact factor: 3.889

6.  TSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growth.

Authors:  X Gao; D Pan
Journal:  Genes Dev       Date:  2001-06-01       Impact factor: 11.361

Review 7.  Liver kinase B1 (LKB1) in the pathogenesis of epithelial cancers.

Authors:  Jennifer L Herrmann; Yevgeniya Byekova; Craig A Elmets; Mohammad Athar
Journal:  Cancer Lett       Date:  2011-03-29       Impact factor: 8.679

Review 8.  Neurologic manifestations of tuberous sclerosis complex.

Authors:  William M McClintock
Journal:  Curr Neurol Neurosci Rep       Date:  2002-03       Impact factor: 5.081

9.  LKB1 catalytic activity contributes to estrogen receptor alpha signaling.

Authors:  Suchita Nath-Sain; Paola A Marignani
Journal:  Mol Biol Cell       Date:  2009-04-15       Impact factor: 4.138

10.  Role of tuberin in neuronal degeneration.

Authors:  Samy L Habib; David Michel; Eliezer Masliah; Bobby Thomas; Han Seok Ko; Ted M Dawson; Hanna Abboud; Robert A Clark; Syed Z Imam
Journal:  Neurochem Res       Date:  2008-03-05       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.